Tebipenem Pivoxil

替比培南酯

Report date: 2026/04/06 20:01:48
QIDP

Base Information

Drug NameTebipenem Pivoxil
Drug Alias NameTebipenemum pivoxilum替比培南匹酯替比培南匹伏酯Tebipenem pivoxilo泰比培南酯 +[18] 
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > β-lactam antibiotics > Cephalosporins antibiotics
Mechanisms of ActionBacterial penicillin-binding protein inhibitors
TargetsBacterial penicillin-binding protein
Therapy Area/IndicationsCommunity Acquired PneumoniaCommunity-acquired bacterial pneumoniaDiabetes Mellitus +[15] 
Global Approved IndicationsOtitis MediaPneumonia, BacterialStreptococcal Infections +[4] 
Approved Indications in ChinaN/A
Original Approved Country/TerritoryJapan
Original Approved Date2009/04/22
Country/TerritoryCzechiaBulgariaUnited States +[19] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesMeiji Seika Pharma
China Registration ClassN/A

Develop Information

Active CompaniesMeiji Seika PharmaGlaxosmithkline PlcMeiji Seika Pharmatech Co Ltd +[9] 
Inactive CompaniesN/A
Active IndicationsCommunity Acquired PneumoniaCommunity-acquired bacterial pneumoniaDiabetes Mellitus +[12] 
Inactive IndicationsRenal InsufficiencyPyelonephritisUrinary Tract Infections

Other Information

ATC CodeJ01DH06
Related LinksWikipediaDrugBankKEGG